Full Text
Global HTA Assessments of Ultra-Orphan Products- A Case Study Of Eculizumab (Soliris) and Iduronate-2-Sulfatase (Elaprase)

Abstract

Authors

A. Paul J. Morawski D.S. Spinner J.J. Doyle E.C. Faulkner J.F. Ransom

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×